BBHvsIDEV
VanEck Biotech ETF against iShares Core MSCI International Developed Markets ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BBH | IDEV | |
|---|---|---|
| Expense ratio | 0.35% | 0.040% |
| Assets | $488M | $32.2B |
| Net flow, 1 month | +$3M | +$892M |
| Net flow, 1 year | −$23M | +$7.3B |
| Return, YTD | +25.5% | +8.6% |
| Return, 1 year | +37.0% | +10.9% |
| Avg daily volume | 12K | 1.9M |
| Holdings | 26 | 2281 |
| Listed | Nov 23, 1999 | Mar 21, 2017 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS